<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03052816</url>
  </required_header>
  <id_info>
    <org_study_id>16-00498</org_study_id>
    <nct_id>NCT03052816</nct_id>
  </id_info>
  <brief_title>Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery</brief_title>
  <acronym>ICET</acronym>
  <official_title>ICE-T Postoperative Multimodal Pain Regimen Compared to the Standard Regimen in Same Day Vaginal Pelvic Reconstructive Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized controlled trial is to determine whether, &quot;ICE-T,&quot; a novel&#xD;
      multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and&#xD;
      tylenol, has improved pain control intake compared to the standard postoperative pain regimen&#xD;
      in patients undergoing vaginal pelvic floor reconstructive surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pelvic floor disorders involve a myriad of complicated, interwoven clinical conditions that&#xD;
      involve pelvic organ prolapse, urinary incontinence, fecal incontinence, and other pathology&#xD;
      involving the genital and lower urinary tract. It is estimated that pelvic floor disorders&#xD;
      affect up to 25% of all adult women in the United States with increasing prevalence with age.&#xD;
      By the age of sixty, 1 in 9 women will undergo surgical intervention for pelvic organ&#xD;
      prolapse and/or incontinence, increasing to 1 in 5 by the age of 80. As the population in the&#xD;
      United States ages, the demand for healthcare for pelvic floor disorders is estimated to&#xD;
      increase up to 40% in the next 30 years.&#xD;
&#xD;
      Despite the prevalence of surgery performed for pelvic floor disorders, there is a paucity of&#xD;
      data on postoperative pain control that is dedicated to female pelvic reconstructive surgery.&#xD;
      In a recent review, there was only one study that evaluated postoperative pain control after&#xD;
      vaginal reconstructive surgery, and the mainstay of therapy was opioid driven. Generally,&#xD;
      postoperative pain control in gynecologic surgery has been opioid driven, frequently&#xD;
      involving multiple narcotics for analgesia, resulting opioid related complications, including&#xD;
      nausea, vomiting, constipation, urinary retention, and central nervous system side effects In&#xD;
      an effort to combat opioid use in gynecologic and female pelvic reconstructive surgery,&#xD;
      multimodal therapy has been gaining momentum with goals of improved pain control and&#xD;
      decreased opioid requirements. Ice packs, toradol, and acetaminophen have been used in&#xD;
      various trials to decrease postoperative opioid requirements in various surgeries.&#xD;
&#xD;
      Ice packs have been shown to be effective in the treatment of postoperative pain after&#xD;
      abdominal midline incisions. A Cochrane Review of patients subject to post vaginal delivery&#xD;
      perineal cooling included 10 randomized controlled trials with1825 patients with some&#xD;
      evidence that local cooling in the form of ice packs, cold gel packs, cold/ice backs may be&#xD;
      effective in pain relief.&#xD;
&#xD;
      Toradol has been extensively studied in a multitude of surgeries including spinal, obstetric,&#xD;
      orthopedic, urologic, and gynecologic. It has been administered preemptively,&#xD;
      intraoperatively, and postoperatively for pain control with evidence that toradol decreases&#xD;
      postoperative subjective pain scores and decreased narcotic use.&#xD;
&#xD;
      Acetaminophen is mainstay for postoperative pain control as part of multimodal pain regimens&#xD;
      to complement other, opioid sparing medications in a multitude of surgeries including&#xD;
      abdominal hysterectomy.&#xD;
&#xD;
      Therefore, the purpose of this randomized controlled study is to determine whether, &quot;ICE-T&quot; a&#xD;
      novel multimodal postoperative pain regimen composed of around the clock ice packs, toradol,&#xD;
      and tylenol, has improved pain control and decrease opioid intake compared to the standard&#xD;
      postoperative pain regimen in patients undergoing vaginal pelvic floor reconstructive&#xD;
      surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scores (VAS)</measure>
    <time_frame>Visual Analog Scores (VAS) Score in the morning of post op day 1 at 7am.</time_frame>
    <description>Visual Analog Scores (VAS) Scores in the morning of post op day 1. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS Scores at 4 Hours Post Surgery</measure>
    <time_frame>VAS Scores at 4 hours post surgery</time_frame>
    <description>VAS Scores at 4 hours post surgery. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Scores 96 Hours After Surgery</measure>
    <time_frame>VAS Scores 96 hours after surgery</time_frame>
    <description>VAS Scores 96 hours after surgery. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Recovery Scores on Post op Day 1</measure>
    <time_frame>Quality of Recovery scores on post op day 1</time_frame>
    <description>Quality of Recovery scores on post op day 1. The QoR-40 is a 40-item quality of recovery score measuring 5 dimensions: physical comfort (12 items), emotional state (9 items), physical independence (5 items), psychological support (7 items), and pain (7 items). Each item is rated on a 5-point Likert scale. The QoR-40 has a possible score of 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It was specifically designed to measure a patient's health status after surgery and anesthesia, and it has been proposed as a measure of outcome in clinical trials.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction Scores in the Morning After Surgery (7AM)</measure>
    <time_frame>Satisfaction scores in the morning after surgery (7AM)</time_frame>
    <description>Satisfaction scores in the morning after surgery (7AM). The satisfaction score is a numerical score from 0-10 with a score of 0 indicating very dissatisfied on the left of the scale and 10 indicating very satisfied on the right of the scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction Scores 96 Hours After Surgery</measure>
    <time_frame>Satisfaction scores 96 hours after surgery</time_frame>
    <description>Satisfaction scores 96 hours after surgery. The satisfaction score is a numerical score from 0-10 with a score of 0 indicating very dissatisfied on the left of the scale and 10 indicating very satisfied on the right of the scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Time from end of surgery to discharge home from hospital, assessed up to 1 week.</time_frame>
    <description>Length of time from the end of surgery to discharge home from the hospital, assessed up to 1 week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Dose of Opioids Administered During Hospitalization</measure>
    <time_frame>Total dose of opioids administered during hospitalization in morphine equivalents from the end of surgery to discharge up to 1 week</time_frame>
    <description>Total dose of opioids administered during hospitalization in morphine equivalents upon hospital discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Nausea and Vomiting at 7AM After Surgery</measure>
    <time_frame>Postoperative nausea and vomiting from the time to end of surgery until 7AM after surgery</time_frame>
    <description>Number of patients with postoperative nausea and vomiting at 7AM after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Urinary Retention.</measure>
    <time_frame>Number of participants with urinary retention (discharge home with foley) measured on day patient is discharged home/study completion up to 1 week.</time_frame>
    <description>Number of participants with urinary retention (discharge home with foley)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>ICE T</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ICE PACKS applied to the perineum every hour for 20 minutes ATC until discharge.&#xD;
6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge.&#xD;
Once out of the PACU will receive 1 gram of Tylenol every 6 hours for a total of 4 grams daily ATC until discharge&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with PO Tylenol and PO toradol PRN.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Motrin 600mg PO Q4h PRN pain 1-3&#xD;
Percocet 1 tab PO Q4-6 hours PRN 4-6 pain&#xD;
Percocet 2 tabs PO Q 7-10 hours PRN 7-10 pain&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with Motrin and Percocet for pain PRN.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ice T</intervention_name>
    <description>Ice/Tylenol/Toradol with dilaudid for breakthrough</description>
    <arm_group_label>ICE T</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Motrin/Percocet/Dilaudid for breakthrough</intervention_name>
    <description>Standard regimen</description>
    <arm_group_label>Standard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The inclusion criteria are the following:&#xD;
&#xD;
          -  Consenting, English speaking women between ages 18 and 80 who will undergo same day&#xD;
             vaginal female pelvic reconstructive surgery at MetroHealth Medical Center&#xD;
&#xD;
          -  Ability to read VAS Scores&#xD;
&#xD;
          -  Specific vaginal procedures include, but are not limited to:&#xD;
&#xD;
               -  Periurethral bulking&#xD;
&#xD;
               -  Perineoplasty&#xD;
&#xD;
               -  Complete vaginectomy&#xD;
&#xD;
               -  Le Forte colpocleisis&#xD;
&#xD;
               -  Anterior repair&#xD;
&#xD;
               -  Posterior repair&#xD;
&#xD;
               -  Enterocele repair&#xD;
&#xD;
               -  Anterior and posterior repair&#xD;
&#xD;
               -  Anterior, posterior and enterocele repair&#xD;
&#xD;
               -  Transvaginal mesh use&#xD;
&#xD;
               -  Sacrospinous ligament fixation&#xD;
&#xD;
               -  Uterosacral ligament suspension&#xD;
&#xD;
               -  Vaginal paravaginal defect repair&#xD;
&#xD;
               -  Midurethral Sling&#xD;
&#xD;
               -  Sphincteroplasty&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus 250 g or less&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or&#xD;
                  ovary(s)&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus 250 g or less; with removal of tube(s), and/or&#xD;
                  ovary(s), with repair of enterocele&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus 250 g or less; with repair of enterocele&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus greater than 250 g&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s)&#xD;
                  and/or ovary(s)&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus greater than 250 g; with removal of tube(s)&#xD;
                  and/or ovary(s), with repair of enterocele&#xD;
&#xD;
               -  Vaginal hysterectomy, for uterus greater than 250 g; with repair of enterocele&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  The exclusion criteria are the following:&#xD;
&#xD;
          -  History of chronic pelvic pain&#xD;
&#xD;
          -  Abdominal surgery&#xD;
&#xD;
          -  Laparoscopic surgery&#xD;
&#xD;
          -  History of psychiatric disease&#xD;
&#xD;
          -  Currently taking analgesic medications&#xD;
&#xD;
          -  Currently taking sedatives&#xD;
&#xD;
          -  Liver disease&#xD;
&#xD;
          -  Renal disease with CrCl &lt; 60cc/min.&#xD;
&#xD;
          -  History of burns from application of ice.&#xD;
&#xD;
          -  Women who did not consent for the study.&#xD;
&#xD;
          -  Intraoperative concern for increased blood loss&#xD;
&#xD;
          -  Unable to speak English&#xD;
&#xD;
          -  Unable to understand VAS Scores&#xD;
&#xD;
          -  Undergoing concomitant abdominal or laparoscopic procedures.&#xD;
&#xD;
          -  Allergy to motrin, toradol, Percocet, Tylenol&#xD;
&#xD;
          -  Active or history of peptic ulcer disease&#xD;
&#xD;
          -  History of GI bleeding or perforation&#xD;
&#xD;
          -  Hemorrhagic diathesis&#xD;
&#xD;
          -  Severe uncontrolled heart failure&#xD;
&#xD;
          -  Inflammatory bowel disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only patients who undergo same day (&lt;24 hour) female pelvic reconstructive surgery</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>January 31, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2017</study_first_posted>
  <results_first_submitted>September 1, 2021</results_first_submitted>
  <results_first_submitted_qc>October 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 6, 2021</results_first_posted>
  <last_update_submitted>October 3, 2021</last_update_submitted>
  <last_update_submitted_qc>October 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Case Western Reserve University</investigator_affiliation>
    <investigator_full_name>Andrey Petrikovets</investigator_full_name>
    <investigator_title>Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydromorphone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 9, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/16/NCT03052816/Prot_SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study approved January 30th, 2017. First patient recruited April 2017. Between April 2017 and April 2018, 138 women who were scheduled for surgery were assessed. 72 patients were excluded. Sixty-six patients were randomized to the ICE-T or Standard protocols. Of the 33 patients who were randomized to the ICE-T regimen, three were excluded after randomization. Ultimately, thirty patients in the ICE-T arm and 33 patients in the Standard arm were analyzed.</recruitment_details>
      <pre_assignment_details>138 Patients assessed for eligibility. 72 patients excluded: 55 not meeting inclusion criteria and 17 declined to participate.&#xD;
66 were randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ICE T Postoperative Pain Regimen</title>
          <description>ICE PACKS applied to the perineum every hour for 20 minutes ATC until discharge.&#xD;
6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge.&#xD;
Once out of the PACU will receive 1 gram of Tylenol every 6 hours for a total of 4 grams daily ATC until discharge&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with PO Tylenol and PO toradol PRN.&#xD;
Ice T: Ice/Tylenol/Toradol with dilaudid for breakthrough</description>
        </group>
        <group group_id="P2">
          <title>Standard Postoperative Pain Regimen</title>
          <description>Motrin 600mg PO Q4h PRN pain 1-3&#xD;
Percocet 1 tab PO Q4-6 hours PRN 4-6 pain&#xD;
Percocet 2 tabs PO Q 7-10 hours PRN 7-10 pain&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with Motrin and Percocet for pain PRN.&#xD;
Motrin/Percocet/Dilaudid for breakthrough: Standard regimen</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Desired opioids</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>There were 66 total patients that were randomized. 3 patients were excluded from the ICE-T arm whereas non were excluded from the Standard arm. 30 patients analyzed in the ICE-T arm and 33 patients in the Standard arm.</population>
      <group_list>
        <group group_id="B1">
          <title>ICE T</title>
          <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
        </group>
        <group group_id="B2">
          <title>STANDARD</title>
          <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="63"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.8" spread="10.1"/>
                    <measurement group_id="B2" value="59.8" spread="12.7"/>
                    <measurement group_id="B3" value="60.7" spread="11.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scores (VAS)</title>
        <description>Visual Analog Scores (VAS) Scores in the morning of post op day 1. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
        <time_frame>Visual Analog Scores (VAS) Score in the morning of post op day 1 at 7am.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>ICE PACKS applied to the perineum every hour for 20 minutes ATC until discharge.&#xD;
6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge.&#xD;
Once out of the PACU will receive 1 gram of Tylenol every 6 hours for a total of 4 grams daily ATC until discharge&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with PO Tylenol and PO toradol PRN.&#xD;
Ice T: Ice/Tylenol/Toradol with dilaudid for breakthrough</description>
          </group>
          <group group_id="O2">
            <title>Standard</title>
            <description>Motrin 600mg PO Q4h PRN pain 1-3&#xD;
Percocet 1 tab PO Q4-6 hours PRN 4-6 pain&#xD;
Percocet 2 tabs PO Q 7-10 hours PRN 7-10 pain&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with Motrin and Percocet for pain PRN.&#xD;
Motrin/Percocet/Dilaudid for breakthrough: Standard regimen</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scores (VAS)</title>
          <description>Visual Analog Scores (VAS) Scores in the morning of post op day 1. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="10" upper_limit="20"/>
                    <measurement group_id="O2" value="40" lower_limit="20" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VAS Scores at 4 Hours Post Surgery</title>
        <description>VAS Scores at 4 hours post surgery. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
        <time_frame>VAS Scores at 4 hours post surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>ICE PACKS applied to the perineum every hour for 20 minutes ATC until discharge.&#xD;
6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge.&#xD;
Once out of the PACU will receive 1 gram of Tylenol every 6 hours for a total of 4 grams daily ATC until discharge&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with PO Tylenol and PO toradol PRN.&#xD;
Ice T: Ice/Tylenol/Toradol with dilaudid for breakthrough</description>
          </group>
          <group group_id="O2">
            <title>Standard</title>
            <description>Motrin 600mg PO Q4h PRN pain 1-3&#xD;
Percocet 1 tab PO Q4-6 hours PRN 4-6 pain&#xD;
Percocet 2 tabs PO Q 7-10 hours PRN 7-10 pain&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with Motrin and Percocet for pain PRN.&#xD;
Motrin/Percocet/Dilaudid for breakthrough: Standard regimen</description>
          </group>
        </group_list>
        <measure>
          <title>VAS Scores at 4 Hours Post Surgery</title>
          <description>VAS Scores at 4 hours post surgery. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35" lower_limit="0" upper_limit="70"/>
                    <measurement group_id="O2" value="50" lower_limit="30" upper_limit="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VAS Scores 96 Hours After Surgery</title>
        <description>VAS Scores 96 hours after surgery. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
        <time_frame>VAS Scores 96 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>VAS Scores 96 Hours After Surgery</title>
          <description>VAS Scores 96 hours after surgery. The VAS is a 100mm scale with a score of no pain on the left of the scale, indicating a score of 0, and a score of worst pain on the right, indicating a score of 10. Patient is instructed to score the scale where they feel is appropriate. Each demarcation in between marks is 10mm and after the patient marks their score it is measured using mm from 0mm-100mm. A score of 0 is 0mm and a score of 10 is 100mm.</description>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" lower_limit="0" upper_limit="30"/>
                    <measurement group_id="O2" value="30" lower_limit="15" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Recovery Scores on Post op Day 1</title>
        <description>Quality of Recovery scores on post op day 1. The QoR-40 is a 40-item quality of recovery score measuring 5 dimensions: physical comfort (12 items), emotional state (9 items), physical independence (5 items), psychological support (7 items), and pain (7 items). Each item is rated on a 5-point Likert scale. The QoR-40 has a possible score of 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It was specifically designed to measure a patient's health status after surgery and anesthesia, and it has been proposed as a measure of outcome in clinical trials.</description>
        <time_frame>Quality of Recovery scores on post op day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Recovery Scores on Post op Day 1</title>
          <description>Quality of Recovery scores on post op day 1. The QoR-40 is a 40-item quality of recovery score measuring 5 dimensions: physical comfort (12 items), emotional state (9 items), physical independence (5 items), psychological support (7 items), and pain (7 items). Each item is rated on a 5-point Likert scale. The QoR-40 has a possible score of 40 (extremely poor quality of recovery) to 200 (excellent quality of recovery). It was specifically designed to measure a patient's health status after surgery and anesthesia, and it has been proposed as a measure of outcome in clinical trials.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="182" lower_limit="158" upper_limit="189"/>
                    <measurement group_id="O2" value="173" lower_limit="164" upper_limit="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction Scores in the Morning After Surgery (7AM)</title>
        <description>Satisfaction scores in the morning after surgery (7AM). The satisfaction score is a numerical score from 0-10 with a score of 0 indicating very dissatisfied on the left of the scale and 10 indicating very satisfied on the right of the scale.</description>
        <time_frame>Satisfaction scores in the morning after surgery (7AM)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction Scores in the Morning After Surgery (7AM)</title>
          <description>Satisfaction scores in the morning after surgery (7AM). The satisfaction score is a numerical score from 0-10 with a score of 0 indicating very dissatisfied on the left of the scale and 10 indicating very satisfied on the right of the scale.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="8" upper_limit="10"/>
                    <measurement group_id="O2" value="10" lower_limit="8" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction Scores 96 Hours After Surgery</title>
        <description>Satisfaction scores 96 hours after surgery. The satisfaction score is a numerical score from 0-10 with a score of 0 indicating very dissatisfied on the left of the scale and 10 indicating very satisfied on the right of the scale.</description>
        <time_frame>Satisfaction scores 96 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction Scores 96 Hours After Surgery</title>
          <description>Satisfaction scores 96 hours after surgery. The satisfaction score is a numerical score from 0-10 with a score of 0 indicating very dissatisfied on the left of the scale and 10 indicating very satisfied on the right of the scale.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="8.5" upper_limit="10"/>
                    <measurement group_id="O2" value="9" lower_limit="8" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay</title>
        <description>Length of time from the end of surgery to discharge home from the hospital, assessed up to 1 week.</description>
        <time_frame>Time from end of surgery to discharge home from hospital, assessed up to 1 week.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay</title>
          <description>Length of time from the end of surgery to discharge home from the hospital, assessed up to 1 week.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.1" spread="3.1"/>
                    <measurement group_id="O2" value="24.1" spread="5.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Dose of Opioids Administered During Hospitalization</title>
        <description>Total dose of opioids administered during hospitalization in morphine equivalents upon hospital discharge.</description>
        <time_frame>Total dose of opioids administered during hospitalization in morphine equivalents from the end of surgery to discharge up to 1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>Total Dose of Opioids Administered During Hospitalization</title>
          <description>Total dose of opioids administered during hospitalization in morphine equivalents upon hospital discharge.</description>
          <units>milligrams of oral morphine equivalents</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.7" spread="31.2"/>
                    <measurement group_id="O2" value="91.2" spread="38.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Nausea and Vomiting at 7AM After Surgery</title>
        <description>Number of patients with postoperative nausea and vomiting at 7AM after surgery</description>
        <time_frame>Postoperative nausea and vomiting from the time to end of surgery until 7AM after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Nausea and Vomiting at 7AM After Surgery</title>
          <description>Number of patients with postoperative nausea and vomiting at 7AM after surgery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Urinary Retention.</title>
        <description>Number of participants with urinary retention (discharge home with foley)</description>
        <time_frame>Number of participants with urinary retention (discharge home with foley) measured on day patient is discharged home/study completion up to 1 week.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ICE T</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
ICE PACKS applied to the perineum Q2h for 20 minutes ATC until discharge&#xD;
Ketorolac 30mg IV Q6h ATC until discharge&#xD;
Acetaminophen 1g PO Q6h ATC until discharge&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Acetaminophen 1 gram PO every 6 hours PRN pain 1-5 #60&#xD;
Ketorolac 10mg PO every 6 hours PRN pain #6-10 #16</description>
          </group>
          <group group_id="O2">
            <title>STANDARD</title>
            <description>• At the end of surgery patients receive 30mg of IV ketorolac.&#xD;
Once out of PACU patients receive:&#xD;
Ibuprofen 600mg PO Q4h PRN pain 1-3&#xD;
Acetaminophen/oxycodone 5mg/325mg 1 tablet PO Q4-6h PRN pain 4-6&#xD;
Acetaminophen/oxycodone 5mg/325mg 2 tablets PO Q4-6h PRN pain 7-10&#xD;
Hydromorphone 0.2mg IV Q3h PRN for breakthrough pain&#xD;
Patients are discharged home with:&#xD;
Ibuprofen 600mg PO Q8h PRN pain 1-5 #60&#xD;
Acetaminophen/oxycodone 5mg/325mg 1-2 tablets Q4-6h PRN pain 6-10 #16</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Urinary Retention.</title>
          <description>Number of participants with urinary retention (discharge home with foley)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Each patient was assessed for adverse events during the course of the entire study extending one month after completion of recruitment to allow for one month after surgery for each patient recruited.</time_frame>
      <desc>An independent data and safety monitoring physician in the Department of Obstetrics and Gynecology at both institutions oversaw the progress of the study.</desc>
      <group_list>
        <group group_id="E1">
          <title>ICE T</title>
          <description>ICE PACKS applied to the perineum every hour for 20 minutes ATC until discharge.&#xD;
6 hours from the time of first dose of surgery patients will receive 30mg of IV toradol ATC until discharge.&#xD;
Once out of the PACU will receive 1 gram of Tylenol every 6 hours for a total of 4 grams daily ATC until discharge&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with PO Tylenol and PO toradol PRN.&#xD;
Ice T: Ice/Tylenol/Toradol with dilaudid for breakthrough</description>
        </group>
        <group group_id="E2">
          <title>Standard</title>
          <description>Motrin 600mg PO Q4h PRN pain 1-3&#xD;
Percocet 1 tab PO Q4-6 hours PRN 4-6 pain&#xD;
Percocet 2 tabs PO Q 7-10 hours PRN 7-10 pain&#xD;
Patients will receive dilaudid 0.2mg IV Q3 hr PRN for breakthrough pain.&#xD;
Patients will be discharged home with Motrin and Percocet for pain PRN.&#xD;
Motrin/Percocet/Dilaudid for breakthrough: Standard regimen</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Andrey Petrikovets MD</name_or_title>
      <organization>UH Hospitals Cleveland Medical Center/MetroHealth Medical Center at time of study protocol</organization>
      <phone>323 243 9091</phone>
      <email>andrepetrikovets@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

